Considering that chronic inflammation is one of the key mechanisms involved in the pathogenesis of MetS [14], in the long term, a decrease in TLR2 response may exert a beneficial effect because it decreases the inflammatory capacity of inflammatory cells, consequently suppressing whole body chronic inflammation. This evidence concerns the gene TLR2 and metabolic syndrome.